Shattuck Labs, Inc. Sale of Stock, Price Per Share
Shattuck Labs, Inc. (STTK) had Sale of Stock, Price Per Share of $6.45 per share as of 2024-12-31, per its 10-Q filed 2025-05-01.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2025-08-14
- 2024-12-31: Sale of Stock, Price Per Share $6.45.
- 2023-12-31: Sale of Stock, Price Per Share $6.45.
- 2023-12-26: Sale of Stock, Price Per Share $6.45.
| Period end | Sale of Stock, Price Per Share |
|---|---|
| 2024-12-31 | $6.45 10-Q · filed 2025-05-01 |
| 2023-12-31 | $6.45 10-Q · filed 2025-08-14 |
| 2023-12-26 | $6.45 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |